Psychotropic medication use among nursing home residents in Austria: A cross-sectional study

BMC Geriatrics

Volumn 9, Issue 1, 2009, Pages

  Mann, Eva ^a   Köpke, Sascha ^b   Haastert, Burkhard ^c   Pitkälä, Kaisu ^d   Meyer, Gabriele ^e  

^a General Practice and Institute for Health Services Research   (Australia)

^b UNIVERSITY OF HAMBURG   (Germany)

^c MediStatistica ^*  (Germany)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PROTHIPENDYL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM; ZOPICLONE; PSYCHOTROPIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; AGGRESSION; ARTICLE; AUSTRIA; BEDTIME DOSAGE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CUSTODY; DRUG UTILIZATION; EXTRAPYRAMIDAL SYMPTOM; FALLING; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; PATIENT ATTITUDE; PRESCRIPTION; PREVALENCE; RESTLESSNESS; RURAL AREA; SEX DIFFERENCE; TREATMENT DURATION; URBAN AREA; UTILIZATION REVIEW; CLINICAL TRIAL; COMPARATIVE STUDY; HOME FOR THE AGED; MIDDLE AGED; MULTICENTER STUDY; NURSING HOME; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; CROSS-SECTIONAL STUDIES; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; PSYCHOTROPIC DRUGS;

EID: 67949106542     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-9-18     Document Type: Article

References (47)

1. Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland. HM Alanen H Finne-Soveri A Noro E Leinonen, Age Ageing 2006 35 5 508 513 10.1093/ageing/afl065 16807310 (Pubitemid 44295640)
2. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. H Hosia-Randell K Pitkälä Drugs Aging 2005 22 9 793 800 10.2165/00002512-200522090-00008 16156683
3. Restraint use among nursing home residents: cross-sectional study and prospective cohort study. G Meyer S Köpke B Haastert I Mühlhauser, J Clin Nurs 2009 18 7 981 990 10.1111/j.1365-2702.2008.02460.x 19284433
4. Psychopharmacological drug treatment in Munich nursing homes. [Article in German]. E Molter-Bock J Hasford T Pfundstein, Z Gerontol Geriatr 2006 39 5 336 343 10.1007/s00391-006-0401-7 17039288 (Pubitemid 44581744)
5. Adverse drug events in high-risk older outpatients. JT Hanlon KE Schmader MJ Koronkowski M Weinberger PB Landsman GP Samsa IK Lewis, J Am Geriatr Soc 1997 45 8 945 948 9256846
6. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. KM Sink KF Holden K Yaffe, JAMA 2005 293 5 596 608 10.1001/jama.293.5.596 15687315 (Pubitemid 40171242)
7. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. C Ballard J Waite, Cochrane Database of Systematic Reviews 2006 1 CD003476 16437455
8. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. LS Schneider PN Tariot KS Dagerman SM Davis JK Hsiao MS Ismail BD Lebowith CG Lyketsos JM Ryan TS Stroup DL Sultzer D Weintraub JA Lieberman CATIE-AD Study Group, N Engl J Med 2006 355 15 1525 1538 10.1056/NEJMoa061240 17035647 (Pubitemid 44547805)
9. Medication as a risk factor for falls: critical systematic review. S Hartikainen E Lönnroos K Louhivuori, J Gerontol A Biol Sci Med Sci 2007 62 10 1172 1181 17921433
10. Atypical Antipsychotics and Parkinsonism. PA Rochon TA Stukel K Sykora S Gill S Garfinkel GM Anderson SL Normand M Mamdani PE Lee P Li SE Bronskill C Marras JH Gurwitz, Arch Intern Med 2005 165 16 1882 1888 10.1001/archinte.165. 16.1882 16157833 (Pubitemid 41352083)
11. Exposure to antipsychotic and risk of stroke: self-controlled case series study. IJ Douglas L Smeeth, BMJ 2008 337 a1227 18755769 10.1136/bmj.a1227
12. Antipsychotic drug use and mortality in older adults with dementia. SS Gill SE Bronskill SL Normand GM Anderson K Sykora K Lam CM Bell PE Lee HD Fischer N Herrmann JH Gurwitz PA Rochon, Ann Intern Med 2007 146 11 775 786 17548409 (Pubitemid 351650498)
13. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. LS Schneider KS Dagerman P Insel, JAMA 2005 294 15 1934 1943 10.1001/jama.294.15.1934 16234500 (Pubitemid 41464695)
14. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. MM Raivio JV Laurila TE Strandberg RS Tilvis KH Pitkälä Am J Geriatr Psychiatry 2007 15 5 416 424 10.1097/JGP.0b013e31802d0b00 17463191
15. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. PS Wang S Schneeweiss J Avorn MA Fischer H Mogun DH Solomon MA Brookhart, N Engl J Med 2005 353 22 2335 2341 10.1056/NEJMoa052827 16319382 (Pubitemid 41713745)
16. Drugs and falls in older people in geriatric care settings. K Kallin Y Gustafson PO Sandman S Karlsson, Aging Clin Exp Res 2004 16 4 270 276 15575120
17. Benzodiazepines and the risk of falls in nursing home residents. WA Ray PB Thapa PJ Gideon, J Am Geriatr Soc 2000 48 6 682 685 10855607
18. Psychotropic drug use in nursing homes- diagnostic indications and variations between institutions. S Ruths J Straand HA Nygaard, Eur J Clin Pharmacol 2001 57 6-7 523 528 11699620
19. Determinants of psychotropic drug utilisation in homes for the elderly and nursing homes. [Article in German]. G Stelzner SG Riedel-Heller A Sonntag H Matschinger A Jakob MC Angermeyer, Z Gerontol Geriatr 2001 34 4 306 312 10.1007/s003910170054 11584715 (Pubitemid 32845242)
20. Determinants fort he use of psychotropics among nursing home residents. L Sorensen A Foldspang NC Gulmann P Munk-Jørgensen, Int J Geriatr Psychiatry 2001 16 2 147 154 10.1002/1099-1166(200102)16:2<147::AID- GPS286>3.0.CO;2-4 11241719
21. Variations in nursing home antipsychotic prescribing rates. PA Rochon TA Stukel SE Bronskill T Gomes KS Sykora WP Wodchis M Hillmer A Kopp JH Gurwitz GM Anderson, Arch Intern Med 2007 167 7 676 683 10.1001/archinte.167.7.676 17420426 (Pubitemid 46598460)
22. Heimaufenthaltsgesetz (HeimAufG), (NR: GP XXII RV 353 AB 378 S. 46. BR:6966, 705). Bundesgesetzblatt für die Republik sterreich Teil I, 11, Bundesgesetz. Austrian Ministry of Social Welfare, Vienna 2004
23. Chemical restraints in nursing homes in the federal state Vorarlberg, Austria - an analysis of nursing home documentation according to legal obligation and suggestions for future improvement. [Article in German]. E Mann G Meyer, Wien Med Wochenschr 2008 158 17-18 489 492 10.1007/s10354-008-0549-4 18807239
24. Anatomical Therapeutic Chemical (ATC) classification index including defined daily doses (DDDs) for plain substances. World Health Organisation, World Health Organisation Collaborating Centre for Drug Statistics Methodology, Oslo 1997
25. Federal Act on Nursing Care [Bundespflegegesetz, BGBl. 110/1993, text of 19 January 1993]. SOZDOK edition Austrian Ministry of Social Welfare, Vienna 1998 51
26. Proxy screening tools improve the recognition of dementia in old-age homes: results of a validation study. L Köhler S Weyerer M Schäufele, Age Aging 2007 36 5 549 554 10.1093/ageing/afm108 (Pubitemid 47554946)
27. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Cohen-Mansfield, J Am Geriatr Soc 1986 34 10 722 727 3760436
28. Design and Analysis of Cluster Randomization Trials in Health Research. A Donner N Klar, London: Arnold 2000
29. Unequal cluster sizes for trials in English and Welsh general practice: implications for sample size calculations. SM Kerry JM Bland, Statistics in Medicine 2001 20 3 377 390 10.1002/1097-0258(20010215)20:3<377::AID- SIM799>3.0.CO;2-N 11180308
30. Regression standard errors in clustered samples. WH Rogers, Stata Technical Bulletin 1993 13 19 23
31. A note on robust variance estimation for cluster-correlated data. RL Williams, Biometric 2000 56 2 645 646 10.1111/j.0006-341X.2000.00645.x
32. Drug utilisation in Dutch nursing homes. KN van Dijk CS de Vries PB van den Berg JR Brouwers LT de Jong-van den Berg, Eur J Clin Pharmacol 2000 55 10 765 771 10.1007/s002280050012 10663457
33. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. IB Holmquist B Svensson P Hoglund, Eur J Clin Pharmacol 2003 59 8-9 669 676 10.1007/s00228-003-0679-y 14517706 (Pubitemid 37494537)
34. Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study. Z Feng JP Hirdes TF Smith H Finne-Soveri I Chi JN Du Pasquier R Gilgen N Ikegami V Mor, Int J Geriatr Psychiatry 2009 19280680
35. Antipsychotic use in the elderly: shifting trends and increasing costs. M Rapoport, Int J Geriatr Psychiatry 2005 20 8 749 753 10.1002/gps.1358 16035128 (Pubitemid 41158720)
36. Expert Consensus Panel for Using antipsychotic agents in older patients. GS Alexopoulos J Streim D Carpenter JP Docherty, J Clin Psychiatry 2004 65 Suppl 2 5 99 14994733
37. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. C Ballard J Waite, Cochrane Database of Systematic Reviews 2006 1 CD003476 DOI: 10.1002/14651858.CD003476. pub2
38. An indicator of appropriate neuroleptic prescribing in nursing homes. CA Oborne R Hooper KC Li CG Swift SH Jackson, Age Ageing 2002 31 6 435 439 10.1093/ageing/31.6.435 12446288 (Pubitemid 35452787)
39. Influence of facility characteristics on use of antipsychotic medications in nursing homes. CM Hughes KL Lapane V Mor, Med Care 2000 38 12 1164 1173 10.1097/00005650-200012000-00003 11186295
40. Resident and organisational factors affecting the quality of drug use in Swedish nursing homes. I Schmidt C Claesson B Westerholm BL Svarstadt, Soc Sci Med 1998 47 961 971 10.1016/S0277-9536(98)00169-5 9722115 (Pubitemid 28370545)
41. Variations in the Treatment Culture of nursing homes and responses to regulations to reduce drug use. BL Svarstadt JK Mount W Bigelow, Psychiatric Services 2001 52 666 672 10.1176/appi.ps.52.5.666 11331803 (Pubitemid 32429298)
42. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. DM Fick JW Cooper WE Wade, Arch Intern Med 2003 163 22 2716 2724 10.1001/archinte.163.22.2716 14662625 (Pubitemid 37517412)
43. Exposure to Inappropriate Drugs and Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland. H Hosia-Randell S Muurinen KH Pitkälä Drugs Ageing 2008 25 8 683 692 18665660 10.2165/00002512- 200825080-00005
44. Factors influencing prescription of CNS medications in different elderly populations. D Craig AP Passmore KJ Fullerton TR Beringer DH Gilmore VL Crawford PM McCaffrey A Montgomery, Pharmacoepidemiol Drug Saf 2003 12 5 383 387 10.1002/pds.865 12899112 (Pubitemid 36903373)
45. Report on sustainability. [Article in German]. J Wallner, Dachverband der Alten- und Pflegeheime sterreichs, Ottakringer Strae, Wien 2006 264 1160
46. How Well do Psychotropic Medications Match Mental Health Diagnoses? A National View of Potential Off-Label Prescribing in VHA Nursing Homes. D French R Campbell AM Spehar J Accomando, Age and Ageing 2007 36 1 107 108 10.1093/ageing/afl131 (Pubitemid 47072046)
47. Geriatric Assessment. [Article in German]. A Welz-Barth C Hader, Dtsch Med Wochenschr 2007 132 1 827 836 10.1055/s-2007-973629 17427095 (Pubitemid 46739678)